Abstract
Prolonged exposure to high levels of glucocorticoids results in a syndrome first described by Cushing. Harvey Williams Cushing (1869–1939) reported the clinical syndrome of amenorrhea, bruising, cutaneous striae, facial plethora, high blood pressure, hirsutism, and myopathy and attributed it to “pituitary basophilism” (1). Bishop and Close were the first to name the new syndrome after Cushing in a case recognized as such the year Cushing published his paper (2). Albright was the first to recognize the role of glucocorticoids in this syndrome (3). A few years later, excessive secretion of corticotropin (ACTH) from pituitary was shown to be the cause of Cushing’s disease (4). The ectopic ACTH syndrome was described by the same person who later established the dexamethasone suppression test, the long-standing golden standard for the differential diagnosis of Cushing’s syndrome (5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cushing HW. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50: 137–195.
Bishop PMF, Close HG. A case of basophil adenoma of the anterior lobe of the pituitary. “Cushing’s Syndrome”. Guy’s Hosp Rep 1932; 82: 143–153.
Albright F. Cushing’s syndrome. Harvey Lecture Ser 1942–1943; 38: 123–186.
Kepler EJ, Sprague RG, Claegt OT, Ower MP, Mason H, Rodgers HM. Adrenocortical tumor associated with Cushing’s syndrome. J Clin Endocrinol 1948; 8: 499–531.
Liddle GW. Tests of pituitary-adrenal supressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Met 1960; 20: 1539.
Quddusi S, Browne P, Toivola B, Hirsch IB. Cushing’s syndrome due to surreptitious glucocorticoid administration. Arch Intern Med 1998; 158: 294–296.
Arioglu E, Doppman J, Gomes M, Kleiner D, Mauro D, Barlow C, et al. Cushing’s syndrome caused by corticotropin secretion by pulmonary tumorlets. N Engl J Med 1998; 339: 883–886.
Selvais P, Donckier J, Buysschaert M, Maiter D. Cushing’s disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. Eur J Endocrinol 1998; 138: 153–159.
Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing’s syndrome. N Engl J Med 1998; 339: 27–31.
Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro-and macronodular disease) leading to Cushing’s syndrome. Horm Metab Res 1998; 30: 456–463.
Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996; 97: 699–705.
Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. The corticotropin-releasing hormone stimulation test following dexamethasone administration (dex/CRH test): a new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. J Am Med Assoc 1993; 269: 2232–2238.
Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998; 19: 647–672.
Miller KK, Daly PA, Sentochnik D, Doweiko J, Samore M, Basgoz NO, et al. Pseudo-Cushing’s syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 27: 68–72.
Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. `Buffalo hump“ in men with HIV-1 infection. Lancet 1998; 351: 867–870.
Leibowitz J, Pertsemilidis D, Gabrilove JL. Recurrent Cushing’ s syndrome due to recurrent adrenocortical tumor-fragmentation of tumor in ectopic adrenal tissue? J Clin Endocrinol Metab 1998; 83: 37863789.
Nguyen KQ, Hoeffel C, Le LH, Phan HT. Mediastinal lipomatosis. South Med J 1998; 91: 1169–1172.
Stratakis CA, Mastorakos G, Mitsiades NS, Mitsiades CS, Chrousos GP. Skin manifestations of Cushing’s disease in children and adolescents before and after the resolution of hypercortisolemia. Pediatr Dermatol 1998; 15: 253–258.
Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin Exp Pharmacol Physiol 1998; 25: S51–56.
Hayashi Y, Takeda Y, Kaneko K, Koyama H, Aiba M, Ideka U, et al. A case of Cushing’s syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids. Endocr J 1998; 45: 485–491.
Koren W, Grienspuhn A, Kuznetsov SR, Berezin M, Rosenthal T, Postnov YV. Enhanced Na+/H+ exchange in Cushing’s syndrome reflects functional hypermineralocorticoidism. J Hypertens 1998; 16: 1187–1191.
Sartorio A, Conti A, Ambrosi B. Bone and collagen turnover in patients with active and preclinical Cushing’s syndrome and in subjects with adrenal incidentaloma. J Clin Endocrinol Metab 1998; 83: 2605–2606.
Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, et al. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing’s syndrome. J Clin Endocrinol Metab 1998; 83: 1863–1867.
Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998; 129: 229–240.
Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, et al. Menstrual abnormalities in women with Cushing’s disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 1998; 83: 3083–3088.
Margioris AN, Chrousos GP. Adrenal disorders. In: Vinken PJ, Bruyn GW, (Ser. eds.); Goetz CG, Aminoff MJ, (Vol eds), Systemic Diseases. Part II. Handbook of Clinical Neurologyl. Vol 70 (Rev. Ser. 26), 1998; Elsevier Science, New York.
Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, et al. Psychopathology in patients with endogenous Cushing’s syndrome: `atypical’ or melancholic features. Clin Endocrinol 1995; 43: 433–442.
Michelson D, Gold PW. Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression. Ann N Y Acad Sci 1998; 840: 717–722.
Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing’s disease. Psychopathology 1998; 31: 302–306.
Loh KC, Fitzgerald PA, Miller TR, Tyrrell JB. Perils and pitfalls in the diagnosis of Cushing’s syndrome. West J Med 1998; 169: 46–50.
Corcuff JB, Tabarin A, Rashedi M, Duclos M, Roger P, Ducassou D. Overnight urinary-free cortisol determination: a screening test for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 1998; 48: 503–508.
Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing’s syndrome. J Clin Endocrinol Metab 1998; 83: 2681–2686.
Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1163–1167.
Mu YM, Takayanagi R, Imasaki K, Ohe K, Ikuyama S, Yanase T, et al. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing’s disease with resistance to a high dose-dexamethasone suppression test. Clin Endocrinol (Oxf) 1998; 49: 301–306.
Tsigos C, Kamilaris TC, Chrousos GP. Adrenal diseases. In: Moore WT, Eastman RC, eds., Diagnostic Endocrinology. Second ed. Mosby, St Louis, MO, 1996, pp 125–156.
Tsigos C, Chrousos GP. Differential diagnosis and management of Cushing’s syndrome. Annu Rev Med 1996; 47: 443–461.
Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. The dexamethasone-suppressed corticotropinreleasing hormone stimulation test differentiates mild Cushing’s disease from normal physiology. J Clin Endocrinol Metab 1998; 83: 348–352.
Oldfield EH, Doppman JL Petrosal versus cavernous sinus sampling. J Neurosurg 1998; 89: 890–893.
Yanovski JA, Nieman LK, Doppman JL, Chrousos GP, Wilder RL, Gold PW, et al. Plasma levels of corticotropin-releasing hormone in the inferior petrosal sinuses of healthy volunteers, patients with Cushing’s syndrome, and patients with pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1485 1488.
Padayatty SJ, Orme SM, Nelson M, Lamb JT, Belchetz PE. Bilateral sequential inferior petrosal sinus sampling with corticotrophin-releasing hormone stimulation in the diagnosis of Cushing’s disease. Eur J Endocrinol 1998; 139: 161–166.
Tabarin A, Laurent F, Catargi B, Olivier-Puel F, Lescene R, Berge J, et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing’s disease. Clin Endocrinol (Oxf) 1998; 49: 293–300.
Matte J, Roufosse F, Rocmans P, Schoutens A, Jacobovitz D, Mockel J. Ectopic Cushing’s syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe 1]octreotide. Postgrad Med J 1998; 74: 108–110.
Teramoto A, Yoshida Y, Sanno N, Nemoto S. Cavernous sinus sampling in patients with adrenocorticotrophic hormone-dependent Cushing’ s syndrome with emphasis on inter-and intracavernous adrenocorticotrophic hormone gradients. J Neurosurg 1998; 89: 762–768.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Margioris, A.N., Chrousos, G.P. (2001). Clinical Presentation and Diagnosis of Cushing’s Syndrome. In: Margioris, A.N., Chrousos, G.P. (eds) Adrenal Disorders. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-101-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-101-5_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-029-8
Online ISBN: 978-1-59259-101-5
eBook Packages: Springer Book Archive